These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1835405)

  • 1. Physiopathology of plasma androstanediol-glucuronide.
    Vermeulen A; Giagulli VA
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):829-33. PubMed ID: 1835405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma androstanediol glucuronide levels during pregnancy.
    van Droogenbroeck J; Vermeulen A
    Clin Endocrinol (Oxf); 1989 Oct; 31(4):425-9. PubMed ID: 2534065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?
    Giagulli VA; Giorgino R; Vermeulen A
    J Steroid Biochem Mol Biol; 1991 Jul; 39(1):55-61. PubMed ID: 1829956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precursors of plasma androstanediol- and androgen-glucuronides in women.
    Giagulli VA; Verdonck L; Giorgino R; Vermeulen A
    J Steroid Biochem; 1989 Nov; 33(5):935-40. PubMed ID: 2532273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.
    Giagulli VA; De Pergola G; Giorgino F; Cignarelli M; Abbaticchio G; Vermeulen A; Giorgino R
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two different pathogenetic mechanisms may play a role in acne and in hirsutism.
    Toscano V; Balducci R; Bianchi P; Guglielmi R; Mangiantini A; Rossi FG; Colonna LM; Sciarra F
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):551-6. PubMed ID: 8252744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is 3 alpha-androstanediol a marker of peripheral hirsutism?
    Toscano V; Sciarra F; Adamo MV; Petrangeli E; Foli S; Caiola S; Conti C
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):314-20. PubMed ID: 6460409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid secretory characteristics of a virilizing adrenal adenoma in a woman.
    Bradshaw KD; Milewich L; Mason JI; Parker CR; MacDonald PC; Carr BR
    J Endocrinol; 1994 Feb; 140(2):297-307. PubMed ID: 8169562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma 3 alpha-androstanediol glucuronide in precocious adrenarche.
    Balducci R; Finocchi G; Mangiantini A; Bianchi P; Guglielmi R; Toscano V
    J Endocrinol Invest; 1993 Feb; 16(2):117-21. PubMed ID: 8463546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H; Rittmaster RS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin modulates peripheral androgen metabolism.
    Serafini P; Lobo RA
    Fertil Steril; 1986 Jan; 45(1):41-6. PubMed ID: 2935426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5 alpha-androstane-3 alpha, 17 beta-diol and 5 alpha-androstane-3 alpha, 17 beta-diol-glucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study.
    Wudy SA; Wachter UA; Homoki J; Teller WM
    Eur J Endocrinol; 1996 Jan; 134(1):87-92. PubMed ID: 8590963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
    Vogt C; Dericks-Tan JS; Kuhl H; Taubert HD
    Gynecol Endocrinol; 1992 Jun; 6(2):85-90. PubMed ID: 1386956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
    Rubens R
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of androstanediol glucuronide, total testosterone, and free testosterone in hirsute women.
    Khoury MY; Baracat EC; Pardini DP; Vieira JG; de Lima GR
    Fertil Steril; 1994 Jul; 62(1):76-80. PubMed ID: 8005308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness.
    De Villez RL; Dunn J
    Arch Dermatol; 1986 Sep; 122(9):1011-5. PubMed ID: 2943232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.